Myogenic regulation of dystrophin gene expression.
Muscle-specific transcriptional regulation of DMD gene expression has been inferred from both the histopathology of the disease and, more recently, from the use of cDNA sequences to detect DMD gene transcripts by Northern blot, RNase protection, in situ hybridization, and polymerase chain reaction (PCR) analyses. Several muscle-specific genes have been shown to be transcriptionally activated early in myogenesis and a number of cis-acting promoter elements required for muscle-specific transcriptional induction have been described. In this report we review our recent progress on studies of the mechanisms underlying myogenic regulation of dystrophin gene expression. Indirect immunofluorescence has been used to demonstrate that dystrophin is present at the muscle cell surface very early in the myogenic program. The cloning and sequencing of the dystrophin gene promoter reveals the presence of pre-defined muscle-specific cis-acting promoter elements. Functional assays provide evidence that these upstream sequences are capable of regulating DMD gene expression in a cell-and developmental stage-specific manner.
Klamut
H J
HJ
Zubrzycka-Gaarn
E E
EE
Bulman
D E
DE
Malhotra
S B
SB
Bodrug
S E
SE
Worton
R G
RG
Ray
P N
PN
D001483:Base Sequence; D016189:Dystrophin; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008969:Molecular Sequence Data; D009124:Muscle Proteins / Q000096:biosynthesis / Q000235:genetics*; D009132:Muscles / Q000166:cytology / Q000378:metabolism*; D016133:Polymerase Chain Reaction
D016189:Dystrophin; D009124:Muscle Proteins